# Type 3 Von Willebrand International Registries Inhibitor Prospective Study

> **NCT02460458** · — · COMPLETED · sponsor: **Fondazione Angelo Bianchi Bonomi** · enrollment: 265 (actual)

## Conditions studied

- Type 3 Von Willebrand's Disease

## Interventions

- **DRUG:** Von Willebrand Factor

## Key facts

- **NCT ID:** NCT02460458
- **Lead sponsor:** Fondazione Angelo Bianchi Bonomi
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-05
- **Primary completion:** 2023-03-28
- **Final completion:** 2023-04-17
- **Target enrollment:** 265 (ACTUAL)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02460458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02460458, "Type 3 Von Willebrand International Registries Inhibitor Prospective Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02460458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*